跳至主要内容
临床试验/2024-513416-98-00
2024-513416-98-00招募中2 期

Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes: A Randomized Open Intervention Study That Compares Empagliflozin, Pioglitazone and Semaglutide (DiaSpax)

Karolinska University Hospital3 个研究点 分布在 2 个国家目标入组 90 人开始时间: 2024年6月11日最近更新:
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
90
试验地点
3
主要终点
Lipolysis is measured as basal and maximal isoprenaline-stimulated lipolysis in isolated adipocytes from the subcutaneous abdominal periumbilical adipose tissue and expressed as log10 ISO-stimulated/basal glycerol release ex vivo

研究概览

简要总结

How do various antidiabetic drugs differ in their beneficial effects on adipose tissue function?

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • The participant has provided written consent to participate in the study
  • HbA1c ≥42 mmol/mol
  • Fertile women must use effective contraception throughout the study. Effective contraception includes any of the following: Combined hormonal contraceptives (estrogen and progestogen) that inhibit ovulation: oral, intravaginal, or transdermal; Progestogen-only contraceptives that inhibit ovulation: oral, injectable, or implantable; Intrauterine device (hormonal or copper); Bilateral tubal occlusion; Vasectomized partner; Sexual abstinence (refraining from heterosexual intercourse throughout the study). Women of childbearing potential need a negative pregnancy test at screening before randomization.

排除标准

  • HbA1C ≥ 65 mmol/mol
  • Insulin treatment
  • Waran or NOAK-treatment
  • Pregnancy, nursing or planned pregnancy
  • Ongoing pregnancy (positive pregnancy test)
  • Positive GAD or IA2 antibodies (Above reference range)
  • Hypersensitivity to the active substance or any of its excipients
  • History of bladder cancer
  • Uninvestigated macroscopic hematuria
  • Low C-peptide/glucose ratio indicative of endogenous insulin deficiency (less than 2 measured as pmol/mg per dL)
  • NT-proBNP 20% above the normal reference value
  • Kidney disease/impairment (eGFR <60 ml/min)
  • Liver disease and/or impairment (hepatic values over twice the upper reference value)
  • Other severe chronic illness including ongoing cancer
  • Established cardiovascular disease and/or heart failure
  • Severe psychiatric condition
  • Active alcoholism

结局指标

主要结局

Lipolysis is measured as basal and maximal isoprenaline-stimulated lipolysis in isolated adipocytes from the subcutaneous abdominal periumbilical adipose tissue and expressed as log10 ISO-stimulated/basal glycerol release ex vivo

Lipolysis is measured as basal and maximal isoprenaline-stimulated lipolysis in isolated adipocytes from the subcutaneous abdominal periumbilical adipose tissue and expressed as log10 ISO-stimulated/basal glycerol release ex vivo

次要结局

  • The cellular heterogeneity of adipose tissue (i.e., different adipocyte subtypes) is measured using qPCR of ADIPOQ/LEP in the same adipose tissue samples from which lipolysis is measured.

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Principal Investigator

Scientific

Karolinska University Hospital

研究点 (3)

Loading locations...

相似试验